Terms: = Skin cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Treatment
23 results:
1. Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.
Mistry K; Levell NJ; Hollestein L; Wakkee M; Nijsten T; Knott CS; Steven NM; Craig PJ; Venables ZC
Br J Dermatol; 2023 Feb; 188(2):228-236. PubMed ID: 36763882
[TBL] [Abstract] [Full Text] [Related]
2. Pro-prion, as a membrane adaptor protein for E3 ligase c-cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.
Li H; Zhang J; Ke JR; Yu Z; Shi R; Gao SS; Li JF; Gao ZX; Ke CS; Han HX; Xu J; Leng Q; Wu GR; Li Y; Tao L; Zhang X; Sy MS; Li C
Cell Rep; 2022 Dec; 41(12):111834. PubMed ID: 36543142
[TBL] [Abstract] [Full Text] [Related]
3. treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.
Chowers G; Abebe-Campino G; Golan H; Vivante A; Greenberger S; Soudack M; Barkai G; Fox-Fisher I; Li D; March M; Battig MR; Hakonarson H; Adams D; Dori Y; Dagan A
Pediatr Res; 2023 Dec; 94(6):1911-1915. PubMed ID: 35246606
[TBL] [Abstract] [Full Text] [Related]
4. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
Pullarkat ST; Wu W; Pullarkat V
Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic and prognostic value of heat shock protein 90α in malignant melanoma.
Zhang T; Li Q; Zhang Y; Wang Q; Wang H; Gu K
Melanoma Res; 2021 Apr; 31(2):152-161. PubMed ID: 33492051
[TBL] [Abstract] [Full Text] [Related]
6. The Patient-Reported Outcome Measures In skin cancer Reconstruction (PROMISCR) study: Anglicisation and initial validation of the FACE-Q skin cancer Module in a UK cohort.
Dobbs TD; Ottenhof M; Gibson JAG; Whitaker IS; Hutchings HA
J Plast Reconstr Aesthet Surg; 2021 Mar; 74(3):615-624. PubMed ID: 33127351
[TBL] [Abstract] [Full Text] [Related]
7. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8
Braun M; Aguilera AR; Sundarrajan A; Corvino D; Stannard K; Krumeich S; Das I; Lima LG; Meza Guzman LG; Li K; Li R; Salim N; Jorge MV; Ham S; Kelly G; Vari F; Lepletier A; Raghavendra A; Pearson S; Madore J; Jacquelin S; Effern M; Quine B; Koufariotis LT; Casey M; Nakamura K; Seo EY; Hölzel M; Geyer M; Kristiansen G; Taheri T; Ahern E; Hughes BGM; Wilmott JS; Long GV; Scolyer RA; Batstone MD; Landsberg J; Dietrich D; Pop OT; Flatz L; Dougall WC; Veillette A; Nicholson SE; Möller A; Johnston RJ; Martinet L; Smyth MJ; Bald T
Immunity; 2020 Oct; 53(4):805-823.e15. PubMed ID: 33053330
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental treatments.
Coquerelle S; Darlington M; Michel M; Durand M; Borget I; Baffert S; Marino P; Perrier L; Durand-Zaleski I;
Value Health; 2020 Jul; 23(7):898-906. PubMed ID: 32762992
[TBL] [Abstract] [Full Text] [Related]
9. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J
Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906
[TBL] [Abstract] [Full Text] [Related]
10. Association of Type of treatment Facility With Overall Survival After a Diagnosis of Head and Neck cancer.
Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
[TBL] [Abstract] [Full Text] [Related]
11. Target therapy versus dacarbazine in first-line treatment of advanced non-surgical and metastatic melanoma: budget impact analysis from the perspective of the Brazilian National Health System, 2018-2020.
Corrêa FM; Guerra RL; Fernandes RRA; Souza MC; Zimmermann IR
Epidemiol Serv Saude; 2019 Jun; 28(2):e2018325. PubMed ID: 31271637
[TBL] [Abstract] [Full Text] [Related]
12. [cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract] [Full Text] [Related]
13. Serum exosomal microRNAs as potent circulating biomarkers for melanoma.
Tengda L; Shuping L; Mingli G; Jie G; Yun L; Weiwei Z; Anmei D
Melanoma Res; 2018 Aug; 28(4):295-303. PubMed ID: 29750752
[TBL] [Abstract] [Full Text] [Related]
14. Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.
Kohn CG; Zeichner SB; Chen Q; Montero AJ; Goldstein DA; Flowers CR
J Clin Oncol; 2017 Apr; 35(11):1194-1202. PubMed ID: 28221865
[TBL] [Abstract] [Full Text] [Related]
15. Head and neck nonmelanoma cutaneous malignancy treatment in a skin cancer referral center.
Stathopoulos P; Igoumenakis D; Shuttleworth J; Frawley T; Ennis C; Battista E; Ameerally P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Feb; 123(2):183-187. PubMed ID: 27989709
[TBL] [Abstract] [Full Text] [Related]
16. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract] [Full Text] [Related]
17. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
Dierks C; Adrian F; Fisch P; Ma H; Maurer H; Herchenbach D; Forster CU; Sprissler C; Liu G; Rottmann S; Guo GR; Katja Z; Veelken H; Warmuth M
Cancer Res; 2010 Aug; 70(15):6193-204. PubMed ID: 20670954
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Results of Carbon Ion Radiotherapy at NIRS.
Tsujii H; Mizoe J; Kamada T; Baba M; Tsuji H; Kato H; Kato S; Yamada S; Yasuda S; Ohno T; Yanagi T; Imai R; Kagei K; Kato H; Hara R; Hasegawa A; Nakajima M; Sugane N; Tamaki N; Takagi R; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
J Radiat Res; 2007; 48 Suppl A():A1-A13. PubMed ID: 17513896
[TBL] [Abstract] [Full Text] [Related]
19. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract] [Full Text] [Related]
20. Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.
Bauer JA; Morrison BH; Grane RW; Jacobs BS; Dabney S; Gamero AM; Carnevale KA; Smith DJ; Drazba J; Seetharam B; Lindner DJ
J Natl Cancer Inst; 2002 Jul; 94(13):1010-9. PubMed ID: 12096086
[TBL] [Abstract] [Full Text] [Related]
[Next]
